Ren Guang, Bhatnagar Sushant, Young Martin E, Lee Timmy, Kim Jeong-A
Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL 35294, USA; UAB Comprehensive Diabetes Center, USA.
Mol Metab. 2025 Mar;93:102099. doi: 10.1016/j.molmet.2025.102099. Epub 2025 Jan 18.
Obesity-associated metabolic dysfunction is a major public health concern worldwide. Endothelial dysfunction is a hallmark of metabolic dysfunction, and endothelial cells affect metabolic functions. Because autophagy-related gene 7 (ATG7) is involved in various cellular physiology, we investigated the roles of endothelial cell-ATG7 (EC-ATG7) on high-fat diet-induced obesity and its related metabolic dysfunction.
We generated an endothelial-specific Atg7 knock-out mouse by breeding Atg7 mouse with the Chd5-Cre mouse, and investigated the metabolic phenotypes associated with high-fat diet (HFD)-induced obesity. Body weight, food intake, glucose tolerance, insulin sensitivity, and liver fat accumulation were measured in endothelial Atg7 deficient (Atg7) and control mice (Atg7). Adipose tissue inflammation was assessed by measuring the expression of pro-inflammatory genes. Furthermore, we performed indirect calorimetry and examined the insulin signaling pathway molecules.
We found that deletion of EC-Atg7 ameliorated HFD-induced weight gain, fatty liver, and adipocyte hypertrophy and inflammatory response in adipose tissue, and improved insulin sensitivity without changing glucose tolerance. These metabolic effects seem to be due to the reduced food intake because there were no differences in energy expenditure, energy excretion to feces, and physical activity. Interestingly, the deletion of EC-Atg7 protected from HFD-induced vascular rarefaction, and the knock-down of Atg7 in endothelial cells protected from fatty acid-induced cell death.
Our results suggest that EC-Atg7 deletion ameliorates HFD-induced obesity and its related metabolic dysfunction, such as insulin resistance and fatty liver by attenuating appetite and vascular rarefaction. The EC-Atg7 deletion may protect the endothelial cells from lipotoxicity and impaired angiogenesis, which preserves the endothelial function in metabolic tissues. These findings may have implications for developing new therapeutic strategies for preventing and treating obesity and its associated health risks.
肥胖相关的代谢功能障碍是全球主要的公共卫生问题。内皮功能障碍是代谢功能障碍的一个标志,且内皮细胞会影响代谢功能。由于自噬相关基因7(ATG7)参与多种细胞生理过程,我们研究了内皮细胞ATG7(EC-ATG7)在高脂饮食诱导的肥胖及其相关代谢功能障碍中的作用。
我们通过将Atg7小鼠与Chd5-Cre小鼠杂交,培育出一种内皮特异性Atg7基因敲除小鼠,并研究与高脂饮食(HFD)诱导的肥胖相关的代谢表型。在内皮Atg7缺陷(Atg7)小鼠和对照小鼠(Atg7)中测量体重、食物摄入量、葡萄糖耐量、胰岛素敏感性和肝脏脂肪堆积情况。通过测量促炎基因的表达来评估脂肪组织炎症。此外,我们进行了间接测热法,并检测了胰岛素信号通路分子。
我们发现,敲除EC-Atg7可改善HFD诱导的体重增加、脂肪肝、脂肪细胞肥大以及脂肪组织中的炎症反应,并改善胰岛素敏感性,而不改变葡萄糖耐量。这些代谢效应似乎是由于食物摄入量减少,因为能量消耗、粪便能量排泄和身体活动方面没有差异。有趣的是,敲除EC-Atg7可预防HFD诱导的血管稀疏,在内皮细胞中敲低Atg7可预防脂肪酸诱导的细胞死亡。
我们的结果表明,敲除EC-Atg7可改善HFD诱导的肥胖及其相关的代谢功能障碍,如通过减弱食欲和血管稀疏来改善胰岛素抵抗和脂肪肝。敲除EC-Atg7可能保护内皮细胞免受脂毒性和血管生成受损的影响,从而维持代谢组织中的内皮功能。这些发现可能对开发预防和治疗肥胖及其相关健康风险的新治疗策略具有启示意义。